Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Completed
- Conditions
- Metastatic DiseaseSquamous Carcinoma Poorly DifferentiatedNeoplasms, Unknown PrimaryPoorly Differentiated CarcinomaCUPPoorly Differentiated Adenocarcinoma
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2018-07-10
- Lead Sponsor
- Foundation Medicine
- Target Recruit Count
- 125
- Registration Number
- NCT02628379
- Locations
- 🇺🇸
Foundation Medicine, Inc, Cambridge, Massachusetts, United States
Concordance Between ctDNA Assay and FoundationOne
Completed
- Conditions
- Circulating Tumor DNANeoplasmsCancerGenomic TestingGenomic Alterations
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Foundation Medicine
- Target Recruit Count
- 1400
- Registration Number
- NCT02620527
- Locations
- 🇺🇸
Foundation Medicine, Cambridge, Massachusetts, United States
FoundationOne™ Test Registry Study
Completed
- Conditions
- TumorNeoplasm MetastasisCancer
- First Posted Date
- 2013-05-10
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Foundation Medicine
- Target Recruit Count
- 510
- Registration Number
- NCT01851213
- Locations
- 🇺🇸
Evergreen Hematology/Oncology, Spokane, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath